ACC not only shows promise in killing cancer cells but also plays a critical role in neutralizing chronic inflammation, a common trait in conditions like Crohn’s and colitis. This dual-action approach indicates that ACC could significantly reduce inflammation, thereby preventing the environment that fosters cancer development. For individuals suffering from chronic inflammatory diseases, ACC offers a beacon of hope by potentially diminishing the severity of their condition and lowering their risk of cancer progression. This highlights ACC’s unique capability to attack the root cause of inflammation-related cancers, providing a preventative and therapeutic advantage.